Martin Stern

Martin Stern

Auto-generated profile, based on publicly available information

Martin Stern

Department of Hematology, University Hospital Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Blood
Verified
Journal Article
Open access
PDF file
MSMartin Stern
Martin Stern
LRLoredana Ruggeri
Loredana Ruggeri
AMAntonella Mancusi
Antonella Mancusi
MBMaria Ester Bernardo
Maria Ester Bernardo
CAClaudia de Angelis
Claudia de Angelis
AVAndrea Velardi
Andrea Velardi
We hypothesized that transplacental leukocyte trafficking during pregnancy, which induces long-term, stable, reciprocal microchimerism in mother and child, might influence outcome of patients with acute leukemia given parental donor haploidentical hematopoietic stem cell transplantation (HSCT). We analyzed the outcome of 118 patients who received transplants for acute leukemia in 2 centers. Patients received highly T cell–depleted haploidentical grafts after myelo-ablative conditioning. Five-year event-free survival was better in patients who received transplants from the mother than from the father (50.6% ± 7.6% vs 11.1% ± 4.2%; P < .001). Better survival was the result of both reduced incidence of relapse and transplantation-related mortality. The protective effect was seen in both female and male recipients, in both lymphoid and myeloid diseases; it was more evident in patients receiving transplants in remission than in chemotherapy-resistant relapse. Incidences of rejection and acute graft-versus-host disease were not significantly influenced. Multivariate analysis confirmed donor sex in parental donor transplantation as an independent prognostic factor for survival (hazard ratio, father vs mother = 2.36; P = .003). In contrast, in a control cohort of patients who received transplants from haploidentical siblings, donor sex had no influence on outcome. Although obtained in a retrospective analysis, these data suggest that the mother of the patient should be preferred as donor for haploidentical HSCT.

1 August 2008 in Blood
Verified
Journal Article
Open access
PDF file
MSMartin Stern
Martin Stern
LRLoredana Ruggeri
Loredana Ruggeri
MCMarusca Capanni
Marusca Capanni
AMAntonella Mancusi
Antonella Mancusi
AVAndrea Velardi
Andrea Velardi
Inhibitory killer cell immunoglobulin receptors (KIR) bind to major histocompatibility complex antigens. Concise knowledge of KIR ligands allows prediction of natural killer (NK)–cell alloreactivity after hematopoietic stem cell transplantation. KIR3DL1 binds to the Bw4 epitope on HLA-B antigens. Although the same epitope is also found on 4 HLA-A antigens (HLA-A23/24/25/32), these are not currently regarded as KIR3DL1 ligands. We show that expression of HLA A*2301, A*2402, or A*3201 but not HLA A*2501 protects target cells from lysis by KIR3DL1+ NK cells. KIR3DL1+ NK cells from donors expressing the Bw4 epitope on an HLA-A antigen only are fully functional and capable of lysing Bw4− target cells. HLA A25 differs at amino acid 90, close to the serologic Bw4 epitope, from A23/24/32 and from Bw4+ HLA-B antigens. These data suggest that HLA-A antigens should be taken into consideration when assessing the potential for NK alloreactivity after hematopoietic stem cell transplantation.

30 May 2008 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MSM. Stern
M. Stern
HEH. Elsässer
H. Elsässer
GHG. Hönger
G. Hönger
JSJ. Steiger
J. Steiger
SSS. Schaub
S. Schaub
CHC. Hess
C. Hess
Viral infection is a common complication after kidney transplantation. The role of natural killer cells (NK cells) in this setting remains unknown. NK cells express activating and inhibitory killer cell immunoglobulin‐like receptors (KIR). We analyzed whether activating KIR genes carried by kidney transplant‐recipients influence the rate of viral infection during the first year after transplantation. In patients with a KIR A/A genotype (n = 40, KIR2DS4 only activating KIR) the rate of cytomegalovirus (CMV) infection and reactivation was 36%, as compared to 20% in transplant recipients with more than one activating KIR gene (KIR B/X genotype, n = 82, p = 0.04). Adjusting for other risk factors in Cox regression, the relative risk of B versus A genotype patients was 0.34 (95% CI 0.15–0.76, p = 0.009). The degree of protection increased with the number of activating KIR genes. Symptomatic CMV disease was only observed in four individuals, all carrying a KIR A/A genotype. As for viral infections other than CMV, and for bacterial infections, no KIR‐linked protective effect could be detected. Also, graft function and the rate‐rejection episodes were similar in KIR A/A and KIR B/X genotype individuals. This study supports a role for activating KIR in the control of CMV infection after kidney transplantation.

16 September 2008 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MSM. Stern
M. Stern
RBR. Brand
R. Brand
TWT. De Witte
T. De Witte
ASA. Sureda
A. Sureda
VRV. Rocha
V. Rocha
AGA. Gratwohl
A. Gratwohl
H-Y encoded gene products were the first to be recognized as clinically relevant minor histocompatibility antigens. Compared to other gender combinations, female donor/male recipient (FDMR) transplants are associated with increased graft-versus-host disease (GvHD), increased transplant-related mortality (TRM) and reduced risk of relapse. Still, their relative impact on transplant outcome remains controversial. We analyzed donor/recipient sex combination in 53 988 patients treated with allogeneic hematopoietic stem cell transplantation (HSCT) between 1980 and 2005. We found a strong increase in chronic GvHD and late TRM and decreased survival in FDMR transplants irrespective of underlying disease. Conversely, FDMR patients had lower relapse rates. The negative effect on survival decreased with advancing disease stage as relapse protection became more important. Effects of H-Y alloreactivity were most pronounced in patients transplanted from HLA-matched donors and in those receiving transplants from an adult donor. Adjustment for acute and chronic GvHD only partially corrected the effects of H-Y alloreactivity. Analysis of the FDMR proportion over time indicated that the frequency of this gender combination has declined in unrelated transplants over the last 10 years. These data define the role of H-Y mismatching in allogeneic HSCT and support the current practice of avoiding female donors for male patients, if possible.

29 November 2010 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
LBL Bühlmann
L Bühlmann
ABAndreas Buser
Andreas Buser
NCN Cantoni
N Cantoni
SGS Gerull
S Gerull
ATA Tichelli
A Tichelli
MSM Stern
M Stern

12 April 2011 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MSM. Stern
M. Stern
KHK. Hadaya
K. Hadaya
GHG. Hönger
G. Hönger
PMP.-Y. Martin
P.-Y. Martin
JSJ. Steiger
J. Steiger
JVJ. Villard
J. Villard
Cytomegalovirus (CMV) infection is a common complication after organ transplantation. Previous studies have demonstrated that activating killer‐cell immunoglobulin‐like receptors (KIR) may reduce the rate of CMV infection. KIR genes can be divided into haplotype A (containing a fixed set of inhibitory receptors) and haplotype B (carrying additional activating KIR genes). The KIR locus is divided into a centromeric and a telomeric portion, both of which may carry A or B haplotype motifs. We studied a cohort of 339 kidney transplant recipients to elucidate which KIR genes protect from CMV infection. CMV infection occurred in 139 patients (41%). Possession of telomeric (hazard ratio 0.64, 95% confidence interval 0.44–0.94, p = 0.02) but not centromeric (HR 0.86, 95% CI 0.60–1.23, p = 0.41) B motifs was associated with statistically significant protection from CMV infection. Due to linkage disequilibrium, we were not able to identify a single protective gene within the telomeric B complex (which may contain the KIR2DS1, KIR3DS1, KIR2DL5A and KIR2DS5 genes). The presence of known or putative ligands to activating KIR did not significantly modify the influence of telomeric B group genes. We confirm that B haplotypes protect from CMV infection after kidney transplantation and show that this arises from telomeric B haplotype genes.